Midgard Science

Labs / Assays & in vitro testing

GlyTech, Inc.

Kyoto, Japan · glytech-inc.com

GMP

GlyTech, Inc. develops glycan production and chemical glycosylation technologies for drug discovery, biopharmaceutical development, and oligonucleotide therapeutics. It serves research and development partners, the biopharmaceutical industry, and the life science community from offices in Kyoto and a laboratory in Sendai, Japan.

Their website has a general contact form; we send your quote request through it.

What they offer

  • Drug discovery and development

    Supports drug development projects using glycan production and chemical glycosylation technologies.

  • Lead discovery using scaffold peptide backbones

    Discovers peptide leads using natural scaffold peptides and an in vitro evolution screening platform.

  • Lead modification using glycans

    Designs and controls glycan position, structure, and number on target compounds by chemical glycosylation.

  • Custom glycan synthesis

    Synthesizes custom glycans and glycan derivatives for specific research, development, and manufacturing needs.

  • Custom glycopeptide synthesis

    Synthesizes homogeneous glycopeptides and glycoproteins with controlled glycoforms.

  • Glycosylation service

    Chemically glycosylates expressed proteins and other materials.

  • Contract API manufacturing

    Provides contract manufacturing of glycopeptides and glycoproteins on a commercialization scale.

  • Physico-chemical characterization

    Offers analysis services for physico-chemical characterization.

  • Structural characterization

    Offers analysis services for structural characterization.

What they work on

Modalities
Small molecule, Antibody, Bispecific, Peptide, Oligonucleotide
Species and models
human-type glycans, animal cells, cDNA screening system
Assays and studies
HPLC, MS
Scale and capacity
research to production scale, minimum order 1.0 mg, up to kilogram-scale glycan intermediate production, milligram to gram scale, commercialization scale
Therapeutic areas
drug discovery, biopharmaceuticals, oligonucleotide therapeutics, biomarker discovery, antibody development, DDS research, infection, inflammation, cancer
Turnaround
2 to 3 months · a further 3 to 4 months
What to send
target and initial criteria · project needs for custom synthesis
Minimums and prices
minimum order 1.0 mg
Sites
Kyoto, Japan · Sendai, Japan
Quality
HPLC and MS analysis (quality confirmation for synthesized glycopeptides/glycoproteins)
Founded
2012

Similar labs. Aurigene Pharmaceutical Services, Sparx BIO, Bioneeds, CDI Labs

Found in a contract services directory. Listing built from glytech-inc.com. Work here? Claim this listing.

GlyTech, Inc. · Midgard Science